Neu an der OTC! TMRO - 500 Beiträge pro Seite
eröffnet am 17.10.00 02:51:59 von
neuester Beitrag 07.05.03 14:45:53 von
neuester Beitrag 07.05.03 14:45:53 von
Beiträge: 25
ID: 271.898
ID: 271.898
Aufrufe heute: 1
Gesamt: 919
Gesamt: 919
Aktive User: 0
Top-Diskussionen
| Titel | letzter Beitrag | Aufrufe |
|---|---|---|
| vor 58 Minuten | 24246 | |
| vor 51 Minuten | 4589 | |
| vor 36 Minuten | 4275 | |
| vor 1 Stunde | 3536 | |
| vor 34 Minuten | 2312 | |
| heute 18:58 | 1975 | |
| heute 18:50 | 1733 | |
| vor 22 Minuten | 1305 |
Meistdiskutierte Wertpapiere
| Platz | vorher | Wertpapier | Kurs | Perf. % | Anzahl | ||
|---|---|---|---|---|---|---|---|
| 1. | 1. | 18.074,66 | -0,48 | 215 | |||
| 2. | 2. | 161,29 | +11,48 | 196 | |||
| 3. | 8. | 9,6550 | -33,46 | 192 | |||
| 4. | 3. | 0,1975 | +3,40 | 72 | |||
| 5. | 9. | 747,45 | -1,89 | 32 | |||
| 6. | 19. | 6,7540 | -2,31 | 32 | |||
| 7. | 5. | 0,0211 | -32,59 | 29 | |||
| 8. | 50. | 56,20 | +1,08 | 28 |
Feedback
TMRO wird erst seit 10 Oktober an der OTC gehandelt.
Die Firma (THERMOELASTIC) hat eine Neue Art Acryl erfunden, mit wunderbaren Anwendungsmöglichkeiten.
Besonders im Zahntechnischen Bereich werden ihm grosse Erfolgschancen eingeräumt.
Aber auch für andere Anwendungsgebiete ist dieser Kunststoff interessant. Wegen seiner leichten Formbarkeit und seiner grossen Aushärtung.
In über 60 Industriezweigen soll er zur Anwendung kommen!
Bericht: http://www.otcnn.com/articles.html?id=971709000
morchel
http://www.zockstocks.de.vu
Die Firma (THERMOELASTIC) hat eine Neue Art Acryl erfunden, mit wunderbaren Anwendungsmöglichkeiten.
Besonders im Zahntechnischen Bereich werden ihm grosse Erfolgschancen eingeräumt.
Aber auch für andere Anwendungsgebiete ist dieser Kunststoff interessant. Wegen seiner leichten Formbarkeit und seiner grossen Aushärtung.
In über 60 Industriezweigen soll er zur Anwendung kommen!
Bericht: http://www.otcnn.com/articles.html?id=971709000
morchel
http://www.zockstocks.de.vu
Bodenbildung bei 1$........
morchel
morchel
Bodenbildung bei 1$........
morchel
morchel
Bzw. ständig pendelnd zwischen 75 Cents und 1$.
Schaue mir die Aktie schon einige Tage an, in der Erwartung, dass sie noch einiges
billiger wird. Pustekuchen. Mit einer Halbierung des Wertes nach dem OTC BB-Listing hat sie
sich sehr gut geschlagen. Steckt aber auch unwahrscheinlich viel Phantasie in dem Papier,
wenn man sieht, wofür dieser Kunststoff angeblich so alles taugt.
Inzwischen hat man auch einen sehr starken Distributionspartner gefunden: "Zahn Dental",
Tochter der "Henry Schein, Inc." (Nasdaq HSIC), welche mit 1,73 Mrd. Umsatz in den ersten
9 Monaten des Jahres aufwarten kann.
http://biz.yahoo.com/prnews/001024/fl_thermoe.html
Was mir noch sehr gut gefällt: bislang erst 17.338.164 outstandig shares. Die können sich seit
dem letzten Filing aber erhöht haben (Stand 18.08.). Wie hoch die authorized shares sind, weiß ich
nicht - für mich ein entscheidender Faktor, da viele OTC-gelistete Unternehmen im Laufe der Zeit soviele
Aktien auf den Markt werfen, dass man sich am Ende bei der tollsten Success-Story über Penny-Preise
nicht mehr wundern darf (Paradebeispiel für mich AMJY). Trotz sehr geringer Umsätze bleiben die
Quartalsverluste im Rahmen (zuletzt 88.610 $) - noch kein großer administrativer overhead. Sehr geringer
Cash-Bestand (1.879 $).
Bleibe am Ball.
Schaue mir die Aktie schon einige Tage an, in der Erwartung, dass sie noch einiges
billiger wird. Pustekuchen. Mit einer Halbierung des Wertes nach dem OTC BB-Listing hat sie
sich sehr gut geschlagen. Steckt aber auch unwahrscheinlich viel Phantasie in dem Papier,
wenn man sieht, wofür dieser Kunststoff angeblich so alles taugt.
Inzwischen hat man auch einen sehr starken Distributionspartner gefunden: "Zahn Dental",
Tochter der "Henry Schein, Inc." (Nasdaq HSIC), welche mit 1,73 Mrd. Umsatz in den ersten
9 Monaten des Jahres aufwarten kann.
http://biz.yahoo.com/prnews/001024/fl_thermoe.html
Was mir noch sehr gut gefällt: bislang erst 17.338.164 outstandig shares. Die können sich seit
dem letzten Filing aber erhöht haben (Stand 18.08.). Wie hoch die authorized shares sind, weiß ich
nicht - für mich ein entscheidender Faktor, da viele OTC-gelistete Unternehmen im Laufe der Zeit soviele
Aktien auf den Markt werfen, dass man sich am Ende bei der tollsten Success-Story über Penny-Preise
nicht mehr wundern darf (Paradebeispiel für mich AMJY). Trotz sehr geringer Umsätze bleiben die
Quartalsverluste im Rahmen (zuletzt 88.610 $) - noch kein großer administrativer overhead. Sehr geringer
Cash-Bestand (1.879 $).
Bleibe am Ball.
hot air
du bist ja ein saustarker fundamentalist.......
muß dich loben über soviel "reinhängungsvermögen"
morchel
du bist ja ein saustarker fundamentalist.......
muß dich loben über soviel "reinhängungsvermögen"
morchel
Trading Spotlight
Danke für die Blumen, Morchel. Ich muß aber noch manches lernen - beschäftige mich erst seit wenigen Monaten
überhaupt mit Aktien, mit OTC-Werten seit einigen Wochen (allerdings kein Jungspund, eher ein Spätberufener).
Dagegen setzt Du mit Deinen Entdeckungen immer wieder Highlights hier im w:o-Board, wobei Du auf allzu reißerische
Aufmacher verzichtest und was Deine Interessen und Strategien anbetrifft mit offenen Karten spielst. Gefällt mir.
Vorbildlich.
Zu den authorized shares habe ich jetzt eine Info gefunden in einem älteren Quartalsreport:
Stockholders` equity:
Preferred stock, par value $.0001, 20,000,000 shares
authorized, no shares issued - -
Common stock, par value $.0001, 100,000,000 shares
authorized, 17,338,164 shares issued and outstanding
http://quote.fool.com/sec/sectext.asp?CIK=1074142&Directory=…
überhaupt mit Aktien, mit OTC-Werten seit einigen Wochen (allerdings kein Jungspund, eher ein Spätberufener).
Dagegen setzt Du mit Deinen Entdeckungen immer wieder Highlights hier im w:o-Board, wobei Du auf allzu reißerische
Aufmacher verzichtest und was Deine Interessen und Strategien anbetrifft mit offenen Karten spielst. Gefällt mir.
Vorbildlich.
Zu den authorized shares habe ich jetzt eine Info gefunden in einem älteren Quartalsreport:
Stockholders` equity:
Preferred stock, par value $.0001, 20,000,000 shares
authorized, no shares issued - -
Common stock, par value $.0001, 100,000,000 shares
authorized, 17,338,164 shares issued and outstanding
http://quote.fool.com/sec/sectext.asp?CIK=1074142&Directory=…
Kaum gelistet, schon Probleme mit der Publikationspflicht.
TMRO wird seit heute als TMROE gehandelt - Abschlag derzeit 22 %.
Mal schaun, ob sie ihr Filing innerhalb der Verlängerungsfrist abgeben,
ansonsten geht`s gleich runter zu den Pink Sheets.
Sehr Vertrauen erweckend!
TMRO wird seit heute als TMROE gehandelt - Abschlag derzeit 22 %.
Mal schaun, ob sie ihr Filing innerhalb der Verlängerungsfrist abgeben,
ansonsten geht`s gleich runter zu den Pink Sheets.
Sehr Vertrauen erweckend!
Das spricht sicher nicht für die Company.....
Mal schauen wie das weitergeht.....
Danke ebenfalls für die Blumen......
morchel
http://www.zockstocks.com
Mal schauen wie das weitergeht.....
Danke ebenfalls für die Blumen......
morchel
http://www.zockstocks.com
Symbol ab heute wieder TMRO, habe aber noch kein Filing gesehen.
SYMBOL CHANGES
15:55 11/30/2000 TMROE** TMRO Thermoelastic Technologies Inc
SYMBOL CHANGES
15:55 11/30/2000 TMROE** TMRO Thermoelastic Technologies Inc
!
Dieser Beitrag wurde vom System automatisch gesperrt. Bei Fragen wenden Sie sich bitte an feedback@wallstreet-online.de
Mann, solche News und niemand will die Aktie! Das riecht nach Einsteigen! Hab ich schon paarmal beobachtet. Bester Einstiegspunkt ist bei einer Flatline und wenn niemand mehr über eine Firma redet. Kaufe am Montag für 0.2.
TORONTO--(BUSINESS WIRE)--June 13, 2001--ThermoElastic Technologies, Inc. (OTCBB:TMRO) is pleased to report that it will commence the shipping of BITEM (Biocompatible Intraoral Thermo Elastic Material) Dental Materials to Europe and the Middle East in July 2001.
As announced earlier, BITEM Dental Materials meet the CE (European Union standard) requirements for sale in the European Union and will be ready for shipping to countries that require CE in July 2001. BITEM Dental Materials for the European market are being produced and shipped to GARRECO (TMRO`s packager and distributor) by ESSCHEM (TMRO`s manufacturer of the BITEM material) in June 2001. GARRECO will package and ship BITEM to dealers in Europe and the Middle East in July 2001.
ThermoElastic Technologies, Inc. recently retained RMS (Regulatory & Marketing Services, Inc.) of New Port Richey, Florida to complete the additional testing required by the FDA for the 510K approval (expedited approval process) of the Dental uses of BITEM in the United States. The Company expects to have the new 510K applications ready for RMS to submit in July 2001 and as we are now producing product we will be ready to ship in the United States as soon as we achieve the FDA approvals for all of the Dental uses of BITEM for which FDA approval has been sought.
The laboratory tests required for DISIFIN Hard Surface Disinfecting Products to achieve approval for sale in the United Sates and Canada from the FDA and EPA in the United States and from HPB in Canada are being prepared in Germany by the manufacturer of DISIFIN, RMP chem.-techn. Spezialprodukte GmbH & Co.KG. Upon the completion of these tests ThermoElastic Technologies, Inc., guided by its consultants will submit DISIFIN Hard Surface Disinfecting Products for FDA, EPA, and HPB approval for sale.
After receiving all of the government approvals for both BITEM and DISIFIN, ThermoElastic Technologies, Inc. expects revenue from the sales of these two product lines to be in excess of USD 10,000,000.00 during the first full year of Marketing.
(This news release includes statements that may constitute forward-looking statements under the safe-harbor provisions of the Private Securities Litigation Reform Act of 1995. Such forward-looking statements are necessary estimates reflecting the best judgment of the party making such statements based upon current information and involve a number of risks and uncertainties. Forward-looking statements contained in this press release or in other public statements of ThermoElastic Technologies, Inc. should be considered in light of those factors. Although ThermoElastic Technologies, Inc. believes the expectations reflected in such forward-looking statements are based on reasonable assumptions, it can give no assurance that its expectations will be met.)
For more information on ThermoElastic Technologies, Inc., BITEM Biocompatible Intraoral Thermo Elastic Material, DISIFIN Hard Surface Disinfecting Products, and OIL CLEAN 2000 Oil Decontamination Agent, please visit the Companies website at www.thermoelastictech.com or contact investor relations at 888 910 2323 or George Osterbauer at ThermoElastic, 416 934 9734.
TORONTO--(BUSINESS WIRE)--June 13, 2001--ThermoElastic Technologies, Inc. (OTCBB:TMRO) is pleased to report that it will commence the shipping of BITEM (Biocompatible Intraoral Thermo Elastic Material) Dental Materials to Europe and the Middle East in July 2001.
As announced earlier, BITEM Dental Materials meet the CE (European Union standard) requirements for sale in the European Union and will be ready for shipping to countries that require CE in July 2001. BITEM Dental Materials for the European market are being produced and shipped to GARRECO (TMRO`s packager and distributor) by ESSCHEM (TMRO`s manufacturer of the BITEM material) in June 2001. GARRECO will package and ship BITEM to dealers in Europe and the Middle East in July 2001.
ThermoElastic Technologies, Inc. recently retained RMS (Regulatory & Marketing Services, Inc.) of New Port Richey, Florida to complete the additional testing required by the FDA for the 510K approval (expedited approval process) of the Dental uses of BITEM in the United States. The Company expects to have the new 510K applications ready for RMS to submit in July 2001 and as we are now producing product we will be ready to ship in the United States as soon as we achieve the FDA approvals for all of the Dental uses of BITEM for which FDA approval has been sought.
The laboratory tests required for DISIFIN Hard Surface Disinfecting Products to achieve approval for sale in the United Sates and Canada from the FDA and EPA in the United States and from HPB in Canada are being prepared in Germany by the manufacturer of DISIFIN, RMP chem.-techn. Spezialprodukte GmbH & Co.KG. Upon the completion of these tests ThermoElastic Technologies, Inc., guided by its consultants will submit DISIFIN Hard Surface Disinfecting Products for FDA, EPA, and HPB approval for sale.
After receiving all of the government approvals for both BITEM and DISIFIN, ThermoElastic Technologies, Inc. expects revenue from the sales of these two product lines to be in excess of USD 10,000,000.00 during the first full year of Marketing.
(This news release includes statements that may constitute forward-looking statements under the safe-harbor provisions of the Private Securities Litigation Reform Act of 1995. Such forward-looking statements are necessary estimates reflecting the best judgment of the party making such statements based upon current information and involve a number of risks and uncertainties. Forward-looking statements contained in this press release or in other public statements of ThermoElastic Technologies, Inc. should be considered in light of those factors. Although ThermoElastic Technologies, Inc. believes the expectations reflected in such forward-looking statements are based on reasonable assumptions, it can give no assurance that its expectations will be met.)
For more information on ThermoElastic Technologies, Inc., BITEM Biocompatible Intraoral Thermo Elastic Material, DISIFIN Hard Surface Disinfecting Products, and OIL CLEAN 2000 Oil Decontamination Agent, please visit the Companies website at www.thermoelastictech.com or contact investor relations at 888 910 2323 or George Osterbauer at ThermoElastic, 416 934 9734.
Kein Mensch nimmt Notiz von dieser Firma und das ist gut so, da kann ich nämlich noch günstig einsteigen.. :-)
ThermoElastic Technologies, Inc. Announces Expansion Into the Middle East and Japan and Progress On FDA
TORONTO--(BUSINESS WIRE)--July 9, 2001--ThermoElastic Technologies, Inc. (OTCBB:TMRO) is pleased to announce the expansion of the distribution and sale of its BITEM Dental Products into Israel and Japan.
The Company has appointed FLEX-DENT L.T.D. of Netanya as its exclusive Distributor/Dealer of BITEM Dental Products for Israel. FLEX-DENT L.T.D. is the Company`s first Distributor/Dealer to be appointed in the Middle East. The Company has received its first order from FLEX-DENT for BITEM Dental Products and will begin shipping product to FLEX-DENT in July, 2001.
The Company is also pleased to announce that it has entered into negotiations with J. MORITA CORPORATION of Japan for the appointment of J. Morita Corporation as the Company`s exclusive Distributor/Dealer for Japan. As part of these negotiations, BITEM Dental Product has been shipped to Morita for its independent testing which will be completed by September 18, 2001. Upon successful completion of testing J. Morita Corporation will become the Company`s exclusive Distributor/Dealer of BITEM Dental Products in Japan and will take steps necessary to obtain all appropriate approvals of BITEM from Japan`s regulatory authorities.
J. Morita Corporation is one of the world`s largest suppliers of Dental Products with manufacturing and distribution centres throughout the world and is particularly active throughout Asia, including Japan, Korea, Singapore and Taiwan. For more information on J. Morita Corporation please go to its website at www.morita.com.
The Company is also pleased to announce that the physical testing required to complete the FDA Application for BITEM Dental Products in the United States will be completed by the last week in July, 2001 and the Company`s 510K Submission to the FDA in respect of its BITEM Dental Products will be filed by the end of July, 2001 with final FDA approval expected within 90 days of the date of filing.
(This news release includes statements that may constitute forward-looking statements under the safe-harbor provisions of the Private Securities Litigation Reform Act of 1995. Such forward-looking statements are necessary estimates reflecting the best judgement of the party making such statements based upon current information and involve a number of risks and uncertainties. Forward-looking statements contained in this press release or in other public statements of ThermoElastic Technologies, Inc should be considered in light of those factors. Although ThermoElastic Technologies, Inc. believes the expectations reflected in such forward-looking statements are based on reasonable assumptions, it can give no assurance that its expectations will be met.)
For more information on ThermoElastic Technologies, Inc., BITEM (BIOCOMPATIBLE INTRAORAL THERMOELASTIC MATERIAL), DISIFIN HARD SURFACE DISIFECTING PRODUCTS AND OIL CLEAN 2000 OIL DECONTAMINATION AGENT, please visit the Company`s website at www.thermoelastictech.com, and e mail the Company by clicking on the link info@thermoelastic.com or contact Investor Relations at 888 910 2323 or call George Osterbauer at ThermoElastic, 416-934-9734.
ThermoElastic Technologies, Inc. Announces Expansion Into the Middle East and Japan and Progress On FDA
TORONTO--(BUSINESS WIRE)--July 9, 2001--ThermoElastic Technologies, Inc. (OTCBB:TMRO) is pleased to announce the expansion of the distribution and sale of its BITEM Dental Products into Israel and Japan.
The Company has appointed FLEX-DENT L.T.D. of Netanya as its exclusive Distributor/Dealer of BITEM Dental Products for Israel. FLEX-DENT L.T.D. is the Company`s first Distributor/Dealer to be appointed in the Middle East. The Company has received its first order from FLEX-DENT for BITEM Dental Products and will begin shipping product to FLEX-DENT in July, 2001.
The Company is also pleased to announce that it has entered into negotiations with J. MORITA CORPORATION of Japan for the appointment of J. Morita Corporation as the Company`s exclusive Distributor/Dealer for Japan. As part of these negotiations, BITEM Dental Product has been shipped to Morita for its independent testing which will be completed by September 18, 2001. Upon successful completion of testing J. Morita Corporation will become the Company`s exclusive Distributor/Dealer of BITEM Dental Products in Japan and will take steps necessary to obtain all appropriate approvals of BITEM from Japan`s regulatory authorities.
J. Morita Corporation is one of the world`s largest suppliers of Dental Products with manufacturing and distribution centres throughout the world and is particularly active throughout Asia, including Japan, Korea, Singapore and Taiwan. For more information on J. Morita Corporation please go to its website at www.morita.com.
The Company is also pleased to announce that the physical testing required to complete the FDA Application for BITEM Dental Products in the United States will be completed by the last week in July, 2001 and the Company`s 510K Submission to the FDA in respect of its BITEM Dental Products will be filed by the end of July, 2001 with final FDA approval expected within 90 days of the date of filing.
(This news release includes statements that may constitute forward-looking statements under the safe-harbor provisions of the Private Securities Litigation Reform Act of 1995. Such forward-looking statements are necessary estimates reflecting the best judgement of the party making such statements based upon current information and involve a number of risks and uncertainties. Forward-looking statements contained in this press release or in other public statements of ThermoElastic Technologies, Inc should be considered in light of those factors. Although ThermoElastic Technologies, Inc. believes the expectations reflected in such forward-looking statements are based on reasonable assumptions, it can give no assurance that its expectations will be met.)
For more information on ThermoElastic Technologies, Inc., BITEM (BIOCOMPATIBLE INTRAORAL THERMOELASTIC MATERIAL), DISIFIN HARD SURFACE DISIFECTING PRODUCTS AND OIL CLEAN 2000 OIL DECONTAMINATION AGENT, please visit the Company`s website at www.thermoelastictech.com, and e mail the Company by clicking on the link info@thermoelastic.com or contact Investor Relations at 888 910 2323 or call George Osterbauer at ThermoElastic, 416-934-9734.
@BII-Aktionär
Du bist nicht allein, bin vor einigen Wochen für 0,21 Dollar mit 15.000 Stück eingestiegen, Kursziel 2,00 Dollar (vielleicht in einem Jahr erreichbar). Wirklich erstaunlich, wie unbekannt die Aktie noch ist bei den News!
Gerd
Du bist nicht allein, bin vor einigen Wochen für 0,21 Dollar mit 15.000 Stück eingestiegen, Kursziel 2,00 Dollar (vielleicht in einem Jahr erreichbar). Wirklich erstaunlich, wie unbekannt die Aktie noch ist bei den News!
Gerd
Thermoelastic weitet die Distribution für seine dentalen BITEM-Produkte jetzt auf 12 Länder aus mit 8 Distributeuren. Das FDA-Approval läßt wahrscheinlich nur noch ca 3,5 Monate auf sich warten. Und in Europa beginnen diesen Monat die ersten Auslieferungen.
Pressemeldung heute:
-------------------
Monday July 16, 6:29 am Eastern Time
Press Release
ThermoElastic Technologies, Inc. Announces Appointment of Four New European Distributors for BITEM
TORONTO--(BUSINESS WIRE)--July 16, 2001--ThermoElastic Technologies, Inc. (TMRO OTC BB) is pleased to announce the expansion of its distribution network for the distribution and sale of its BITEM Dental Products into EIGHT (8) additional European Countries as follows:
AUSTRIA, CZECH REPUBLIC
& SLOVAKIA: ERIK LIEHMANN
Zahnwaren, Grosshandlung
Spittelweis 15
A-4020 Linz
THE NETHERLANDS: ACACIA DENTAL
Trawlerkade 28
1926 CB
Ijmuiden
The Netherlands
BELGIUM & LUXEMBURG: LEO VAN KLEEF
14, Rue des Crayats
BE.6464 Baileux
SPAIN & PORTGUGAL: F. BIOCONSULTING S.L.
c/Ramon Gomez de la Serna 107
1 B Madrid, Spain 28035
This now brings the number of countries in Europe and the Middle East in which BITEM will be distributed to twelve (12) through eight (8) Distributor/Dealers. Watch for future announcements of the appointment of Distibutors/Dealers for Germany, Switzerland, France, Turkey, Denmark, Sweden and Croatia for BITEM Dental Products.
In accordance with previous announcements, shipment of BITEM Dental Products to European countries will begin this month, July, 2001.
The Company is also pleased to announce that the physical testing required to complete the FDA Application for BITEM Dental Products in the United States will be completed by the last week in July, 2001 and the Company`s 510K Submission to the FDA in respect of its BITEM Dental Products will be filed by the end of July, 2001 with final FDA approval expected within 90 days of the date of filing.
http://biz.yahoo.com/bw/010716/0044.html
Pressemeldung heute:
-------------------
Monday July 16, 6:29 am Eastern Time
Press Release
ThermoElastic Technologies, Inc. Announces Appointment of Four New European Distributors for BITEM
TORONTO--(BUSINESS WIRE)--July 16, 2001--ThermoElastic Technologies, Inc. (TMRO OTC BB) is pleased to announce the expansion of its distribution network for the distribution and sale of its BITEM Dental Products into EIGHT (8) additional European Countries as follows:
AUSTRIA, CZECH REPUBLIC
& SLOVAKIA: ERIK LIEHMANN
Zahnwaren, Grosshandlung
Spittelweis 15
A-4020 Linz
THE NETHERLANDS: ACACIA DENTAL
Trawlerkade 28
1926 CB
Ijmuiden
The Netherlands
BELGIUM & LUXEMBURG: LEO VAN KLEEF
14, Rue des Crayats
BE.6464 Baileux
SPAIN & PORTGUGAL: F. BIOCONSULTING S.L.
c/Ramon Gomez de la Serna 107
1 B Madrid, Spain 28035
This now brings the number of countries in Europe and the Middle East in which BITEM will be distributed to twelve (12) through eight (8) Distributor/Dealers. Watch for future announcements of the appointment of Distibutors/Dealers for Germany, Switzerland, France, Turkey, Denmark, Sweden and Croatia for BITEM Dental Products.
In accordance with previous announcements, shipment of BITEM Dental Products to European countries will begin this month, July, 2001.
The Company is also pleased to announce that the physical testing required to complete the FDA Application for BITEM Dental Products in the United States will be completed by the last week in July, 2001 and the Company`s 510K Submission to the FDA in respect of its BITEM Dental Products will be filed by the end of July, 2001 with final FDA approval expected within 90 days of the date of filing.
http://biz.yahoo.com/bw/010716/0044.html
...es muß heißen
Liehmann L & Co GmbH, Zahnwarengroßhdlg, Spittelwiese 15 4020 Linz
0732 772445-0
FAX
0732 783054
falls jemand Auskünfte in Deutsch einholen will!
aber von mir habt ihr das nicht!
morchel
Vorwahl für Österreich 0043
Liehmann L & Co GmbH, Zahnwarengroßhdlg, Spittelwiese 15 4020 Linz
0732 772445-0
FAX
0732 783054
falls jemand Auskünfte in Deutsch einholen will!
aber von mir habt ihr das nicht!
morchel
Vorwahl für Österreich 0043
Danke Morchel,
werde dort vermutlich in den nächsten Tagen mal anrufen!
Gerd
werde dort vermutlich in den nächsten Tagen mal anrufen!
Gerd
Eingeschlafen hier..dabei Supernews!
+ 157% in NY!
ThermoElastic Technologies, Inc. Announces the Completion Of New BITEM Submissions to FDA and Confirmation That DISIFIN Is Effective in Killing Anthrax
TORONTO, Oct. 29 /PRNewswire/ -- ThermoElastic Technologies, Inc (OTC Bulletin Board: TMRO) is pleased to announce that the European developer of DISIFIN has advised TMRO that current testing of DISIFIN confirms that solutions as low as 0.05% of DISIFIN kills ANTHRAX active status bacteria as well as all other gram positive and gram negative bacteria found on hard surfaces such as those found in hospital, health care facilities, food processing plants, animal farms, health clubs hotels and homes. Presently, the Company is working to complete the required testing to meet the EPA requirements for its DISIFIN solid disinfectant products and expects to be submitting the completed EPA Application for DISIFIN early in the new year.
The Company is also pleased to announce that the additional testing required by the FDA for the 510K approval process for the uses of BITEM (Biocompatible Intraoral Thermo Elastic Material) Dental Products that were not previously approved has been completed and the new 510K Application for these BITEM Dental Products was submitted to the FDA during the last week of August, 2001. FDA Approval is expected by the end of November or early December 2001 and will enable TMRO to launch the sale of BITEM Dental Products in the United States.
In Europe and the Middle East BITEM is now being distributed and sold in twelve (12) countries including England, Italy, Greece, Austria, Czech Republic, Slovakia, The Netherlands, Belgium, Luxembourg, Spain, Portugal and Israel. TMRO anticipates that the worldwide sales of its BITEM Products and sales in the US and Canada of DISIFIN Products in the 12 months following receipt of all pending FDA Applications will reach $10,000,000 to $12,000,000.
Dental distribution in the United States has been organized through Zahn Dental, a Henry Schein Company. The Company will commence delivery of BITEM Dental Products for sale in the United States from existing inventories as soon as FDA Approval has been received.
(This news release includes statements that may constitute forward-looking statements under the safe-harbor provisions of the Private Securities Litigation Reform Act of 1995. Such forward-looking statements are necessary estimates reflecting the best judgment of the party making such statements based upon current information and involve a number of risks and uncertainties. Forward-looking statements contained in this press release or in other public statements of ThermoElastic Technologies, Inc should be considered in light of those factors. Although ThermoElastic Technologies, Inc. believes the expectations reflected in such forward-looking statements are based on reasonable assumptions, it can give no assurance that its expectations will be met.)
+ 157% in NY!
ThermoElastic Technologies, Inc. Announces the Completion Of New BITEM Submissions to FDA and Confirmation That DISIFIN Is Effective in Killing Anthrax
TORONTO, Oct. 29 /PRNewswire/ -- ThermoElastic Technologies, Inc (OTC Bulletin Board: TMRO) is pleased to announce that the European developer of DISIFIN has advised TMRO that current testing of DISIFIN confirms that solutions as low as 0.05% of DISIFIN kills ANTHRAX active status bacteria as well as all other gram positive and gram negative bacteria found on hard surfaces such as those found in hospital, health care facilities, food processing plants, animal farms, health clubs hotels and homes. Presently, the Company is working to complete the required testing to meet the EPA requirements for its DISIFIN solid disinfectant products and expects to be submitting the completed EPA Application for DISIFIN early in the new year.
The Company is also pleased to announce that the additional testing required by the FDA for the 510K approval process for the uses of BITEM (Biocompatible Intraoral Thermo Elastic Material) Dental Products that were not previously approved has been completed and the new 510K Application for these BITEM Dental Products was submitted to the FDA during the last week of August, 2001. FDA Approval is expected by the end of November or early December 2001 and will enable TMRO to launch the sale of BITEM Dental Products in the United States.
In Europe and the Middle East BITEM is now being distributed and sold in twelve (12) countries including England, Italy, Greece, Austria, Czech Republic, Slovakia, The Netherlands, Belgium, Luxembourg, Spain, Portugal and Israel. TMRO anticipates that the worldwide sales of its BITEM Products and sales in the US and Canada of DISIFIN Products in the 12 months following receipt of all pending FDA Applications will reach $10,000,000 to $12,000,000.
Dental distribution in the United States has been organized through Zahn Dental, a Henry Schein Company. The Company will commence delivery of BITEM Dental Products for sale in the United States from existing inventories as soon as FDA Approval has been received.
(This news release includes statements that may constitute forward-looking statements under the safe-harbor provisions of the Private Securities Litigation Reform Act of 1995. Such forward-looking statements are necessary estimates reflecting the best judgment of the party making such statements based upon current information and involve a number of risks and uncertainties. Forward-looking statements contained in this press release or in other public statements of ThermoElastic Technologies, Inc should be considered in light of those factors. Although ThermoElastic Technologies, Inc. believes the expectations reflected in such forward-looking statements are based on reasonable assumptions, it can give no assurance that its expectations will be met.)
Bin draussen seit vorgestern at 0.16! hätte vielleicht noch 1 tag warten sollen. höchst war heute 0.20! aber bin zufrieden und den idealen punkt erwischt man selten. werde an der seitenlinie bleiben. falls der kurs nochmals unter 0.10 gehen sollte, steige ich wieder ein..
So, Alleinunterhalter biiaktionär ist wieder da! lol
was seh ich da? tmro bei 0.06?? ui,ui, zum glück hab ich zu 0.16 verkauft. jetzt werf ich grad eine kauforder zu 0.05 rein....
was seh ich da? tmro bei 0.06?? ui,ui, zum glück hab ich zu 0.16 verkauft. jetzt werf ich grad eine kauforder zu 0.05 rein....
Wow, hatte ich dussel. war mal vor paar monaten bei 0.10 eingestiegen, ging dann runter auf 0.06 und ich hatte schon muffensausen. Dann kam ein Push wegen dem Anthrax und die aktie ging auf ca. 0.20! ich konnte grad noch bei 0.16 verkaufen... :-)
so, und nun sind wir bei 0.005 (hab ich genügend nullen?). Nach dem Filing der Fa. gings bergab. Ich rühre die Aktie auch nicht mehr an. Habt ihr das Filing angeschaut? Die Fa. mach Riesen-Millionen-Verluste bei Verkäufen von ein paar Tausend Dollar. Ein Witz.
Langsam glaube ich, das Material, das sie herstellen ist nur schwer verkäuflich.
Das ist es eben bei einer 1-Produkte-Firma. Kann super laufen oder bös in die Hose gehen.
Ich kauf keine Aktie mehr! :-)
so, und nun sind wir bei 0.005 (hab ich genügend nullen?). Nach dem Filing der Fa. gings bergab. Ich rühre die Aktie auch nicht mehr an. Habt ihr das Filing angeschaut? Die Fa. mach Riesen-Millionen-Verluste bei Verkäufen von ein paar Tausend Dollar. Ein Witz.
Langsam glaube ich, das Material, das sie herstellen ist nur schwer verkäuflich.
Das ist es eben bei einer 1-Produkte-Firma. Kann super laufen oder bös in die Hose gehen.
Ich kauf keine Aktie mehr! :-)
Kurs jetzt 0.0014! dilution...dilution...no news....dilution...no sales....no news... schrottaktie... wann kommt der reverse-split?
Was nützt das beste Ding, wenns keiner haben will, egal aus welchen Gründen!
morchel
morchel
LOl. lustig die aktie wieder einmal anzuschaun... jetzt bei 0.06 NACH dem (vorausgesagten) Reverse-Splitt! Die ganze Bude könnte man jetzt für 20`000 Dollar kaufen... oje.... LOL
kürzel ist jetzt THME.
Wer kauft den schrott noch? ab und zu gibts nämlich tatsächlich kleine umsätze... lol
kürzel ist jetzt THME.
Wer kauft den schrott noch? ab und zu gibts nämlich tatsächlich kleine umsätze... lol
DurchsuchenBeitrag zu dieser Diskussion schreiben
Zu dieser Diskussion können keine Beiträge mehr verfasst werden, da der letzte Beitrag vor mehr als zwei Jahren verfasst wurde und die Diskussion daraufhin archiviert wurde.
Bitte wenden Sie sich an feedback@wallstreet-online.de und erfragen Sie die Reaktivierung der Diskussion oder starten Sie eine neue Diskussion.
Meistdiskutiert
| Wertpapier | Beiträge | |
|---|---|---|
| 213 | ||
| 196 | ||
| 195 | ||
| 71 | ||
| 33 | ||
| 32 | ||
| 28 | ||
| 26 | ||
| 25 | ||
| 24 |
| Wertpapier | Beiträge | |
|---|---|---|
| 23 | ||
| 22 | ||
| 21 | ||
| 20 | ||
| 20 | ||
| 20 | ||
| 20 | ||
| 19 | ||
| 19 | ||
| 19 |
